These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4156356)

  • 21. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteriological and pharmacological properties of new cephalosporin antibiotics. I. Cephalothin 1].
    Naumann P
    Arzneimittelforschung; 1966 Jul; 16(7):818-25. PubMed ID: 4384924
    [No Abstract]   [Full Text] [Related]  

  • 23. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 24. Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model.
    Esposito S; Noviello S; Ianniello F
    J Chemother; 2000 Dec; 12(6):475-81. PubMed ID: 11154028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacteriological and pharmacological properties of new cephalosperine antibiotics. II. Cephaloridine].
    Naumann P
    Arzneimittelforschung; 1967 Apr; 17(4):469-81. PubMed ID: 4386771
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan.
    Hsueh PR; Teng LJ; Lee LN; Yang PC; Ho SW; Lue HC; Luh KT
    Microb Drug Resist; 2002; 8(1):27-33. PubMed ID: 12002646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
    Giovanetti E; Montanari MP; Marchetti F; Varaldo PE
    J Antimicrob Chemother; 2000 Dec; 46(6):905-8. PubMed ID: 11102408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of kitasamycin in a general practice situation.
    Stratford BC; Dixson S
    Med J Aust; 1974 Jun; 1(26):1029-31. PubMed ID: 4855146
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative in vitro activity of cephalosporins.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1976 Feb; 29(2):181-6. PubMed ID: 6411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro postantibiotic effect of roxithromycin and erythromycin against gram-positive cocci.
    Chang JC; Hsueh PR; Young C
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):276-84. PubMed ID: 1342645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications.
    Kaplan EL; Chhatwal GS; Rohde M
    Clin Infect Dis; 2006 Dec; 43(11):1398-406. PubMed ID: 17083011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
    Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
    Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sensitivity of staphylococci to antibiotics].
    Hromadka A; Hohenegger M
    Chemotherapy; 1966; 11(6):355-64. PubMed ID: 5338948
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates.
    Klugman KP; Capper T; Widdowson CA; Koornhof HJ; Moser W
    J Antimicrob Chemother; 1998 Dec; 42(6):729-34. PubMed ID: 10052895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vitro activity of ceftobiprole against Gram-positive cocci.
    Betriu C; Culebras E; Gómez M; López-Fabal F; Rodríguez-Avial I; Picazo JJ
    Int J Antimicrob Agents; 2010 Aug; 36(2):111-3. PubMed ID: 20554163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antimicrobial susceptibility and serotypes of Streptococcus pneumoniae isolated from the patients with respiratory tract infections in Hokusetsu Area of Osaka].
    Sugita K; Wakamiya E; Nishimura T; Oguni T; Yoshikawa K; Hijioka S; Kugo Y; Sugiki M; Uemura T; Inoue S
    Jpn J Antibiot; 2000 Jul; 53(7):512-21. PubMed ID: 11019385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time.
    McDonald PJ; Craig WA; Kunin CM
    J Infect Dis; 1977 Feb; 135(2):217-23. PubMed ID: 839090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of Staphylococcus aureus, Streptococcus pyogenes and Diplococcus pneumoniae to antibiotics. Comparison of patterns in Poland and Federal Republic of Germany.
    Jeljaszewicz J; Stochmal I; Dajek Z; Pulverer G; Hryniewicz W; Cybulska J; Switalski LM; Dziarski R
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(4):376-85. PubMed ID: 10702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inducible clindamycin resistance in β-hemolytic streptococci and Streptococcus pneumoniae.
    Megged O; Assous M; Weinberg G; Schlesinger Y
    Isr Med Assoc J; 2013 Jan; 15(1):27-30. PubMed ID: 23484235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.
    Nagai K; Davies TA; Ednie LM; Bryskier A; Palavecino E; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3242-5. PubMed ID: 11600391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.